Sergei N. Pokrovsky

15A, 3d Cherepkovskaya Street
Moscow, MOW 121552, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Lipoprotein(a) Concentration and Achieving Target Values of Low-Density Lipoprotein Cholesterol Calculated by Different Equations.

Lipoprotein(a) Concentration and Achieving Target Values of Low-Density Lipoprotein Cholesterol Calculated by Different Equations.

Journal: Diseases (Basel, Switzerland)

Published: November 27, 2025

Role of Lipoprotein(a) and Blood Cells Ratios in Peripheral Artery Disease.

Role of Lipoprotein(a) and Blood Cells Ratios in Peripheral Artery Disease.

Journal: International journal of molecular sciences

Published: September 08, 2025

Lipoprotein(a) and Blood Monocytes as Factors for Progression of Carotid Atherosclerosis in Patients with Premature Coronary Heart Disease.

Lipoprotein(a) and Blood Monocytes as Factors for Progression of Carotid Atherosclerosis in Patients with Premature Coronary Heart Disease.

Journal: Diseases (Basel, Switzerland)

Published: April 15, 2025

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease.

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease.

Journal: Diseases (Basel, Switzerland)

Published: July 01, 2023

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis.

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis.

Journal: Diseases (Basel, Switzerland)

Published: December 31, 2021

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease.

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease.

Journal: Journal of personalized medicine

Published: December 29, 2021

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction.

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction.

Journal: Frontiers in cardiovascular medicine

Published: December 26, 2021

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis.

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis.

Journal: Journal of cardiovascular development and disease

Published: April 20, 2021

A Sorbent with Synthetic Ligand for Removing Pro-atherogenic and Pro-inflammatory Components from Human Blood Plasma.

A Sorbent with Synthetic Ligand for Removing Pro-atherogenic and Pro-inflammatory Components from Human Blood Plasma.

Journal: Acta naturae

Published: March 22, 2021

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries.

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries.

Journal: Biomolecules

Published: December 30, 2020

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease.

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease.

Journal: Journal of cardiovascular development and disease

Published: December 28, 2020

The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients

The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients

Journal: Terapevticheskii arkhiv

Published: October 23, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026